OVERVIEW
Amid the coronavirus pandemic, the molecular quality control market size is expected to grow over the forecast period at a CAGR of 9.65%. The growth of this market is mainly driven by factors such as the increasing adoption of quality controls by third parties, the increasing number of certified clinical laboratories, and the increasing demand for support for external quality assurance. The report will also account for COVID-19 as a key market contributor.TABLE OF CONTENT
- 1 Global Molecular Quality Controls Market
- 1.1 Study Objectives
- 1.2 Market Definition
- 1.3 Study Scope
- 1.3.1 Markets Covered
- 1.3.2 Geographic Scope
- 2 RESEARCH METHODOLOGY
- 2.1 Research Data
- 2.1.1 Secondary Data
- 2.1.1.1 Key Data From Secondary Sources
- 2.1.2 Primary Data
- 2.1.2.1 Key Data From Primary Sources
- 2.1.2.2 Key Industry Insights
- 2.1.2.3 Breakdown of Primaries
- 2.1.1 Secondary Data
- 2.2 Market Size Estimation
- 2.2.1 Bottom-Up Approach
- 2.2.2 Top-Down Approach
- 2.3 Market Breakdown and Data Triangulation
- 2.4 Research Assumptions
- 2.1 Research Data
- 3 Global Molecular Quality Controls Market – Executive Summary
- 3.1 Market Revenue, Market Size and Key Trends by Company
- 3.2 Key Trends by type of Application
- 3.3 Key Trends segmented by Geography
- 4 Global Molecular Quality Controls Market – Comparative Analysis
- 4.1 Product Benchmarking - Top 10 companies
- 4.2 Top 5 Financials Analysis
- 4.3 Market Value split by Top 10 companies
- 4.4 Patent Analysis - Top 10 companies
- 4.5 Pricing Analysis
- 5 Global Molecular Quality Controls Market – Industry Market Entry Scenario
- 5.1 Regulatory Framework Overview
- 5.2 New Business and Ease of Doing business index
- 5.3 Case studies of successful ventures
- 5.4 Customer Analysis – Top 10 companies
- 6 Global Molecular Quality Controls Market - Market Forces
- 6.1 Introduction
- 6.2 Market Dynamics
- 6.2.1 Drivers
- 6.2.2 Opportunities
- 6.2.3 Challenges
- 6.3 Porters Analysis of Market
- 6.3.1 Bargaining power of suppliers
- 6.3.2 Bargaining powers of customers
- 6.3.3 Threat of new entrants
- 6.3.4 Rivalry among existing players
- 6.3.5 Threat of substitutes
- 7 Global Molecular Quality Controls Market - Strategic Analysis
- 7.1 Value Chain analysis
- 7.2 Product Life Cycle
- 7.3 Supplier and distributor analysis (Market share and product dealing strategies)
- 8 Global Molecular Quality Controls Market – By Product (Market Size – & million/billion)
- 8.1 Handheld instruments
- 8.2 Accessories
- 9 Global Molecular Quality Controls Market - By Procedure
- 9.1 Subscription
- 9.2 Ownership
- 10 Global Molecular Quality Controls Market - By Application
- 10.1 Gastrointestinal & Abdominal Surgeries
- 10.2 Gynecological Surgeries
- 10.3 Cardiovascular Surgeries
- 10.4 Urological Surgeries
- 10.5 Other
- 11 Global Molecular Quality Controls Market - By End-User
- 11.1 Hospitals
- 11.2 Other
- 12 Global Molecular Quality Controls Market – By Geography (Market Size – &
- 12.1 Introduction
- 12.2 North America
- 12.2.1 US
- 12.2.2 Canada
- 12.2.3 Mexico
- 12.3 Europe
- 12.3.1 U.K
- 12.3.2 Germany
- 12.3.3 Italy
- 12.3.4 France
- 12.3.5 Spain
- 12.3.6 Rest of Europe
- 12.4 Asia-Pacific
- 12.4.1 China
- 12.4.2 Japan
- 12.4.3 India
- 12.4.4 South Korea
- 12.4.5 Rest of APAC
- 12.5 Rest of the World
- 12.5.1 South America
- 12.5.2 Middle East
- 12.5.3 Africa
- 13 Global Molecular Quality Controls Market – Entropy
- 13.1 New product launches
- 13.2 M&A's, collaborations, JVs and partnerships
- 14 Global Molecular Quality Controls Market Company Profile (Key Players)
- 14.1 Market Share, Company Revenue, Products, M&A, Developments
- 14.2 Medtronic
- 14.3 Johnson & Johnson
- 14.4 The Cooper Companies, Inc.
- 14.5 Conmed Corporation
- 14.6 B. Braun Melsungen AG
- 14.7 Grena Think Medical
- 14.8 Genicon, Inc.
- 14.9 Teleflex Incorporated
- 14.10 Olympus Corporation
- 14.11 Applied Medical Resources Corporation
- 14.12 Company 11 & more
- 15 Global Molecular Quality Controls Market - Appendix
- 15.1 Sources
- 15.2 Abbreviations
Molecular Quality Controls Market by Application (Infectious Diseases), by Product (Instrument Specific (DNA Sequencing), Independent), by Analyte Type (Multi, Single), End User (Research Institute, IVD Manufacturers) – 2022 to 2027
Category: HealthcareSKU: GMS-1183
×